High dose dry powder inhalers to overcome the challenges of tuberculosis treatment

Article ID	Journal	Published Year	Pages	File Type
10137512	International Journal of Pharmaceutics	2018	63 Pages	PDF

Keywords

FDA EPTB DOTS PTB PASA MTB XDR-TB MDR-TB tmax DPI PLA FPF Cmax TDR-TB PLGA AUC Poly-lactic acid AIDS Tuberculosis Pulmonary delivery maximum serum concentration Spray-drying Intravenous High dose emitted dose time to reach Cmax World Health Organization Food and Drug Administration Pulmonary TB acquired immunodeficiency syndrome Intramuscular Alveolar macrophage Mycobacterium tuberculosis area under the curve Particle engineering human immunodeficiency virus HIV poly(lactic-co-glycolic) acid Dry powder inhaler Fine particle fraction WHO

Related Topics

Health Sciences Pharmacology, Toxicology and Pharmaceutical Science Pharmaceutical Science

High dose dry powder inhalers to overcome the challenges of tuberculosis treatment

Authors

Mohammad A.M. Momin, Ian G. Tucker, Shyamal C. Das,